Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02989857
Title Study of AG-120 in Previously Treated Advanced Cholangiocarcinoma With IDH1 Mutations (ClarIDHy)
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Agios Pharmaceuticals, Inc.
Indications

cholangiocarcinoma

Therapies

Ivosidenib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST